As of January 22, 2025, Repare Therapeutics (RPTX) has a market cap of $51.438 million USD. According to our data, Repare Therapeutics is ranked No.8136 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $51.44 M |
-7.63%
|
Dec 31, 2024 | $55.69 M |
-82.05%
|
Dec 29, 2023 | $0.31 B |
-50.37%
|
Dec 30, 2022 | $0.63 B |
-30.25%
|
Dec 31, 2021 | $0.90 B |
-38.51%
|
Dec 31, 2020 | $1.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Arvinas
ARVN
|
$1.25 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Market Cap | = | RPTX Stock Price | * | RPTX Shares Outstanding |
= | $1.21 | * | 42.51 M | |
= | $51.44 M |